Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Prioritise educating GPs over patients, says patient advocate

Jack Whelan says that patients are ‘no different to the man on the street’ with health knowledge 

Webinar: How to conduct effective market research in emerging markets

Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.

Inizio

- PMLiVE

Merck Serono joins CAR-T race with $941m Intrexon deal

Will collaborate on therapy to recognise and attack antigens on tumour cells

Webinar: Uncovering hidden insights into patient compliance

Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

Inizio

Webinar: The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

Inizio

Webinar: Ensuring an actionable segmentation

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

Inizio

Webcast: Leveraging the ASEAN opportunities

Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

Inizio

Webcast: Biosimilars: Friend or Foe to Healthcare?

Understanding the opportunities for biosimilars and the threats to innovator biologics

Inizio

Webinar: Understanding the patient journey in China

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Inizio

- PMLiVE

Google and J&J team up for robotic surgery

Two firms looking to revolutionise medical technology

Teva Pharma logo

Teva starts M&A push with $3.5bn Auspex buy

Aims to diversify business away from dependency on Copaxone

- PMLiVE

Novartis cancer pill makes it onto UK early access list

Joins Merck’s melanoma drug Keytruda for the MHRA’s accelerated review programme 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links